Mandate

Vinge advises the founders of Future Media Group in conjunction with the sale to Caybon

Vinge has advised the founders Rikard Virta, Linus Wennerström and Johan Oscarsson as well as the other shareholders in conjunction with the sale of Future Media Group AB to Caybon.

Future Media Group specialises in helping media owners and growth companies to generate new revenue streams through business development, product development and sales. In close co-operation with its partners, new advertising formats, media solutions and marketing concepts are developed, and the solutions to the correct target groups are prepared in conjunction with the different sales organisations specialising in different types of products and customer segments.

Future Media Groups current partners currently include large media groups such as Bonnier and Stampen, as well as niche actors such as Preglife (the Nordic Region’s leading pregnancy app) and the digital veterinary service, Firstvet. The company has offices in Stockholm and Oslo and employs approximately 100 persons. 

Vinges team has primarily consisted of Jonas JohanssonCarl SanderEllinor Wargenbrant and Linus Adolfsson (M&A), as well as Sara Dahlros Sköld and Ellinore Boström Andersson (VDR).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026